Time course of serial cystatin C levels in comparison with serum creatinine after application of radiocontrast media

Clinical Nephrology

Volumn 61, Issue 2, 2004, Pages 98-102

  Rickli, Hans ^a   Benou, K ^a   Ammann, P ^a   Fehr, Th ^a   Brunner La Rocca, H P ^a   Petridis, H ^a   Riesen, W ^a   Wuthrich R P ^a  

^a CANTONAL HOSPITAL ST GALLEN   (Switzerland)

Author keywords

Coronary angiography; Creatinine; Cystatin C; Radiocontrast nephrotoxicity

Indexed keywords

ALPHA 1 MICROGLOBULIN; BIOCHEMICAL MARKER; CONTRAST MEDIUM; CREATININE; CYSTATIN C; IOPAMIDOL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANGIOPLASTY; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; KIDNEY TUBULE DAMAGE; KINETICS; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY;

EID: 1242273872     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP61098     Document Type: Article

References (23)

1. Agrawal M, Stouffer GA 2002 Cardiology Grand Rounds from The University of North Carolina at Chapel Hill. Contrast-induced nephropathy after angiography. Am J Med Sci 323: 252-258
2. Brady HR, Singer GG 1995 Acute renal failure. Lancet 346: 1533-1540
3. Cockcroft DW, Gault HM 1976 Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41
4. Dharnidharka VR, Kwon C, Stevens G 2002 Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 40: 221-226
5. Finney H, Newman DJ, Gruber W, Merle P, Price CP 1997 Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II). Clin Chem 43: 1016-1022
6. Grubb A, Simonsen O, Sturfelt G, Truedsson L, Thysell H 1985 Serum concentration of cystatin C, factor D and β2-microglobulin as a measure of glomerular filtration rate. Acta Med Scand 218: 499-503
7. Gruberg L, Mintz GS, Mehran R, Gangas G, Lansky AJ, Kent KM, Pichard AD, Satler LF, Leon MB 2000 The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 36: 1542-1548
8. Harmoinen AP, Kouri TT, Wirta OR, Lehtimaki TJ, Rantalaiho V, Turjanma VM, Pasternack AI 1999 Evaluation of plasma cystatin C as a marker for glomerular filtration rate in patients with type 2 diabetes. Clin Nephrol 52: 363-370
9. Kyhse-Andersen J, Schmidt C, Nordin G, Andersson B, Nilsson-Ehle P, Lindstrom V, Grubb A 1994 Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem 40: 1921-1926
10. Le Feuvre C, Dambrin G, Helft G, Tabet S, Beygui F, Legendre C, Peraldi MN, Vacheron A, Metzger JP 2000 Comparison of clinical outcome following coronary stenting or balloon angioplasty in dialysis versus non-dialysis patients. Am J Cardiol 85: 1365-1368
11. Moore RD, Steinberg EP, Powe NR, Brinker JA, Fishman EK, Graziano S, Gopalan R 1992 Nephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial. Radiology 182: 649-655
12. Mussap M, Ruzzante N, Varagnolo M, Plebani M 1998 Quantitative automated particle-enhanced immunonephelometric assay for the routinary measurement of human cystatin C. Clin Chem Lab Med 36: 859-865
13. Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J, Farid N, MeManamon PJ 1989 Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 320: 143-149
14. Plebani M, Dall'Amico R, Mussap M, Montini G Ruzzante N, Marsilio R, Giordano G, Zacchello G 1998 Is serum cystatin C a sensitive marker of glomerular filtration rate (GFR)? A preliminary study on renal transplant patients. Ren Fail 20: 303-309
15. Priem F, Althaus H, Jung K, Sinha P 2001 Beta-trace protein is not better than cystatin C as an indicator of reduced glomerular filtration rate. Clin Chem 4 7: 2181
16. Rich MW, Crecelius CA 1990 Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. Arch Intern Med 150: 123 7-1242
17. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, Singh M, Bell MR, Barsness GW, Mathew V, Garratt KN, Holmes DR Jr 2002 Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105: 2259-2264
18. Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, Hill JA, Winniford M, Cohen MB, VanFossen DB 1995 Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int 47: 254-261
19. Solomon R 1998 Contrast medium-induced acute renal failure. Kidney Int 53: 230-242
20. Taliercio CP, Vlietstra RE, Fisher LD, Burnett JC 1986 Risks for renal dysfunction with cardiac angiography. Ann Intern Med 104: 501-504
21. Ting HH, Tahirkheli NK, Berger PB, McCarthy JT, Timimi FK, Mathew V, Rihal CS, Hasdai D, Holmes DR Jr 2001 Evaluation of long-term survival after successful percutaneous coronary intervention among patients with chronic renal failure. Am J Cardiol 87: 630-633
22. Weisberg LS, Kurnik PB, Kurnik BR 1994 Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int 45: 259-265
23. Yoshioka T, Fogo A, Beckman JK 1992 Reduced activity of antioxidant enzymes underlies contrast media-induced renal injury in volume depiction. Kidney Int 41: 1008-1015